Skip to content

The Healthcare News Network

Your daily guide to Medicare, insurance, medicines and staying well

Monday, October 26, 2026● Updated 6:00 AM ET
Daily edition

Healthcare news for October 26, 2026

Have a stand-alone Medicare drug plan? Don't let it auto-renew. Some premiums are jumping $50 a month or more If you have Original Medicare plus a separate Part D drug plan, 2027 is a year to shop carefully. Medicare is ending a temporary subsidy it paid to stand-alone drug plans, and KFF's analysis finds there will be no $0-premium plans next year for people who don't get Extra Help. That means about 4 million people who paid nothing this year will owe a premium. Choices are shrinking too: the typical beneficiary will have 9 stand-alone plans to pick from, down from 11. Members who stay in AARP Medicare Rx Preferred face increases of $50 or more a month in every state, though every area has cheaper options, and low-cost plans under $8 a month are offered in most states. The yearly cap on what you pay for covered drugs rises to $2,400, up from $2,100. Open your Annual Notice of Change, enter your exact drugs and pharmacy in the Medicare Plan Finder, and compare total yearly cost, not just the premium. Free SHIP counselors and 1-800-MEDICARE can help. You have until Dec. 7 to switch.

In 30 seconds

Medicare & Seniors

  • Snowbirds: your Medicare Advantage plan can drop you after six months away

    Federal rules generally require an Advantage plan to disenroll members who stay outside its service area for more than six straight months, even if they haven't moved for good. Some plans offer a traveler benefit that stretches this to 12 months, but it varies by plan and state, and using out-of-network care doesn't pause the clock. If you are dropped, a special window opens to pick new coverage, and missing it can leave you without drug coverage.

    24/7 Wall St.
  • Thinking of skipping Medicare open enrollment? Take a look first

    You can keep your current plan, but plans change their costs, drug lists and doctor networks every year. Reviewing your 2027 options before Dec. 7 could turn up a cheaper drug or Advantage plan, or reveal that your doctors are leaving your network. You can also use this window to move from Medicare Advantage back to Original Medicare.

    The Motley Fool
  • At least 35 health systems are leaving some Medicare Advantage networks

    Hospital systems including Kettering Health, Sentara and Mayo Clinic have dropped or are dropping contracts with major Advantage insurers such as UnitedHealthcare, Humana, Aetna and Anthem, often citing prior-approval denials and slow payment. If your doctors or hospital belong to one of these systems, confirm they will still be in network in 2027 before you choose a plan.

    Becker's Hospital Review

Insurance & ACA

  • Pennsylvania, New Jersey and Delaware open ACA sign-up on Nov. 1

    Average 2027 premium increases range from about 1.4% to 35% on Pennsylvania's Pennie, depending on the plan, and about 15% to 36% in New Jersey. About 214,000 Pennsylvanians have dropped Pennie plans since last November, but officials say roughly nine in 10 buyers there qualify for savings. Pennsylvanians should enroll by Dec. 15 for Jan. 1 coverage; New Jersey's deadline for Jan. 1 is Dec. 31. Delaware uses HealthCare.gov.

    WHYY
  • Federal workers and retirees face another double-digit premium jump

    The employee and retiree share of Federal Employees Health Benefits premiums will rise 10.9% on average in 2027, the third double-digit increase in a row, while Postal Service plan premiums rise 8.2%. Some plans are going up far more, and adding a family member now requires proof of eligibility. Open season runs Nov. 9 through Dec. 14, so compare plans before staying put.

    Government Executive

Medicines & FDA

  • FDA warns of counterfeit eye drops sold in several Southern states

    Fake versions of Ocusan and Manzanilla Sophia red-eye and dry-eye drops have turned up in Florida and Georgia, mostly in stores serving Spanish-speaking customers, and may be in Louisiana, Mississippi and North Carolina. Two products tested positive for bacteria, which can cause serious eye infections. Counterfeits have Spanish-only labels and no Drug Facts panel. Stop using them and see a doctor if you notice redness, discharge or pain.

    FDA
  • First once-a-week insulin approved for kids with type 2 diabetes

    The FDA has cleared Awiqli, a long-acting insulin injected once weekly, for children 10 and older with type 2 diabetes, after approving it for adults earlier this year. Low blood sugar is the most common side effect and can be serious. Because it is dosed differently from daily insulins, families should double-check the dose on the pen before every shot.

    FDA
  • Natural Grocers recalls organic mung beans over possible glass

    Customers reported sharp glass pieces in 2-pound bags of Natural Grocers brand organic mung beans sold in 22 states, mostly in the West and Plains. Check for UPC 000080112600 and pack dates 26-160, 26-173, 26-196, 26-224 or 26-258. No injuries have been reported. Throw the beans away or return them for a refund.

    FDA

Staying Well

  • U.S. measles cases reach 4,588, double all of last year

    CDC data through Oct. 22 show 178 new cases in a week. About one in 10 patients has been hospitalized, rising to 16% among children under 5. Nearly all cases are in people who were unvaccinated or whose status is unknown. Two MMR doses are about 97% effective, so check your family's records and ask your doctor if anyone is missing a dose.

    Contagion Live
  • WHO update: Ebola has now reached Kenya and Nigeria

    The Congo outbreak has topped 9,700 confirmed cases and 4,600 deaths. Kenya has nine cases tied to one imported case, and Nigeria has one imported case in isolation. WHO rates the global risk as low and advises against travel bans. The strain involved has no approved vaccine or specific treatment. No U.S. cases have been reported.

    World Health Organization

Policy & Law

  • House panel probes whether big PBMs targeted pharmacies with audits

    The House Oversight Committee is investigating whether Optum Rx, CVS Caremark and Express Scripts sent extra audits to independent pharmacies that publicly backed a bill to change how pharmacies are paid in the federal employee health plan. The chairman cited one audit of a 99-cent drug that took staff hundreds of hours. CVS said it will respond; Optum Rx declined to comment.

    Becker's Hospital Review
  • Why health care keeps getting harder to afford

    U.S. health spending hit nearly $5.3 trillion in 2024, and the typical family spends about $5,600 a year, or 9% of income, on premiums, out-of-pocket costs and health taxes. Employer health costs are projected to rise 9.5% in 2027. People in the story cut bills by asking for self-pay rates and applying for hospital financial aid, which many nonprofit hospitals must offer.

    KFF Health News

Hospitals & Business